Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001116354-11-000006
Filing Date
2011-07-18
Accepted
2011-07-18 15:40:41
Documents
1
Period of Report
2011-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5732
  Complete submission text file 0001116354-11-000006.txt   7415
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 233 EAST REDWOOD ST BALTIMORE MD 21202
Business Address
Poliakoff Abba David (Reporting) CIK: 0001423066 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 11972661